ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for deadly thyroid cancer: testing a powerful drug duo
Disease control Recruiting nowThis study is testing whether a combination of two existing drugs, pembrolizumab and lenvatinib, can help control a very aggressive and hard-to-treat form of thyroid cancer. It will involve about 20 adults with anaplastic thyroid cancer that cannot be fully removed by surgery. Th…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New Two-Drug attack on deadly thyroid cancer before surgery
Disease control Recruiting nowThis early-stage study is testing whether giving two drugs, XL092 and cemiplimab, before surgery is safe and helpful for people with a very aggressive type of thyroid cancer that lacks a specific genetic change (BRAF V600E). The goal is to see if this drug combination can shrink …
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC